GLP-1 agonists are FDA-approved for weight loss, offering the most consistent and proven results
[103] Due to safety concerns, including reports of hepatotoxicity and limitations in clinical evidence, the Committee on Herbal Medicinal Products (HMPC) concluded in 2017 that the benefit-risk balance for the oral use of kava in the treatment of anxiety disorders is unfavorable, and therefore a European Union herbal monograph could not be established
Travel, long shifts, dehydration after intense exercise
Our doctor-owned practice emphasizes your health in every way
Aquaculture Nutrition 2011;17:98-115.d
Why the Advanced Recomp Stack Adds CJC/Ipa to Retatrutide Foundation: Retatrutide Retatrutide alone produced the strongest weight-loss results documented in clinical trials: 24.2% mean body weight reduction at 48 weeks in Phase 2 [NEJM 2023] and 28.7% at 68 weeks in Phase 3 (TRIUMPH-4, December 2025)